FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1863095676> ?p ?o ?g. }

• W1863095676 endingPage "841" @default.
• W1863095676 startingPage "837" @default.
• W1863095676 abstract "Abstract Background The role of adjuvant chemotherapy in patients with stage II colon cancer is unclear. Current guidelines recommend adjuvant chemotherapy for high‐risk patients, although the benefit demonstrated to date is small. Our study examined if adjuvant chemotherapy is associated with improved cancer‐specific survival in high‐risk patients with stage II colon cancer. Methods A retrospective review was performed on patients with stage II ( T 3‐4 N 0 M 0) colon cancer in a multi‐institutional database from 1999 to 2007. Additionally, histology slides were reviewed and cancer‐specific survival data were obtained from the state cancer registry. Adverse features examined were perforation, obstruction, T 4 disease, poor differentiation, nodal yield less than 12, lymphovascular invasion and perineural invasion. Survival analysis was performed using the K aplan– M eier method and C ox regression. Results There were 458 patients in the study, with a median follow‐up of 5.2 years. Four patients (0.8%) were lost to follow‐up. There were 290 (63%) high‐risk patients, defined as having at least one adverse feature. Patients who had adjuvant chemotherapy were significantly younger (median 61 years versus 72 years, P < 0.001) but had comparable ASA score (median 2 versus 2, P = 0.3). There was no significant survival benefit observed associated with any one factor or when grouped. In high‐risk patients the 5‐year cancer specific survival with adjuvant chemotherapy was 84.8% (95% CI 78.7–91.9) compared to surgery alone 92.7% (95% CI 88.5–96.1), P = 0.85). Conclusion Adjuvant chemotherapy did not significantly improve cancer‐specific survival in patients with stage II colon cancer with adverse features. Other markers for selecting appropriate patients for adjuvant treatment are required." @default.
• W1863095676 created "2016-06-24" @default.
• W1863095676 creator A5010307492 @default.
• W1863095676 creator A5014636346 @default.
• W1863095676 creator A5042059092 @default.
• W1863095676 creator A5060655524 @default.
• W1863095676 creator A5064444666 @default.
• W1863095676 creator A5065389707 @default.
• W1863095676 date "2013-11-14" @default.
• W1863095676 modified "2023-10-18" @default.
• W1863095676 title "Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer" @default.
• W1863095676 cites W1555609187 @default.
• W1863095676 cites W1591654223 @default.
• W1863095676 cites W1839179899 @default.
• W1863095676 cites W1949303498 @default.
• W1863095676 cites W1964481452 @default.
• W1863095676 cites W1975404145 @default.
• W1863095676 cites W1990748886 @default.
• W1863095676 cites W1995218551 @default.
• W1863095676 cites W2007084094 @default.
• W1863095676 cites W2067493741 @default.
• W1863095676 cites W2103474120 @default.
• W1863095676 cites W2109740395 @default.
• W1863095676 cites W2141768150 @default.
• W1863095676 cites W2162102504 @default.
• W1863095676 cites W2162746289 @default.
• W1863095676 cites W2167177168 @default.
• W1863095676 cites W2774163082 @default.
• W1863095676 doi "https://doi.org/10.1111/ans.12444" @default.
• W1863095676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24224835" @default.
• W1863095676 hasPublicationYear "2013" @default.
• W1863095676 type Work @default.
• W1863095676 sameAs 1863095676 @default.
• W1863095676 citedByCount "16" @default.
• W1863095676 countsByYear W18630956762014 @default.
• W1863095676 countsByYear W18630956762015 @default.
• W1863095676 countsByYear W18630956762016 @default.
• W1863095676 countsByYear W18630956762017 @default.
• W1863095676 countsByYear W18630956762018 @default.
• W1863095676 countsByYear W18630956762019 @default.
• W1863095676 countsByYear W18630956762020 @default.
• W1863095676 countsByYear W18630956762021 @default.
• W1863095676 countsByYear W18630956762022 @default.
• W1863095676 crossrefType "journal-article" @default.
• W1863095676 hasAuthorship W1863095676A5010307492 @default.
• W1863095676 hasAuthorship W1863095676A5014636346 @default.
• W1863095676 hasAuthorship W1863095676A5042059092 @default.
• W1863095676 hasAuthorship W1863095676A5060655524 @default.
• W1863095676 hasAuthorship W1863095676A5064444666 @default.
• W1863095676 hasAuthorship W1863095676A5065389707 @default.
• W1863095676 hasConcept C121608353 @default.
• W1863095676 hasConcept C126322002 @default.
• W1863095676 hasConcept C141071460 @default.
• W1863095676 hasConcept C143998085 @default.
• W1863095676 hasConcept C146357865 @default.
• W1863095676 hasConcept C151730666 @default.
• W1863095676 hasConcept C191897082 @default.
• W1863095676 hasConcept C192562407 @default.
• W1863095676 hasConcept C197934379 @default.
• W1863095676 hasConcept C2776694085 @default.
• W1863095676 hasConcept C2777154038 @default.
• W1863095676 hasConcept C2778456384 @default.
• W1863095676 hasConcept C2778527123 @default.
• W1863095676 hasConcept C2778740770 @default.
• W1863095676 hasConcept C2779013556 @default.
• W1863095676 hasConcept C526805850 @default.
• W1863095676 hasConcept C71924100 @default.
• W1863095676 hasConcept C86803240 @default.
• W1863095676 hasConcept C90924648 @default.
• W1863095676 hasConceptScore W1863095676C121608353 @default.
• W1863095676 hasConceptScore W1863095676C126322002 @default.
• W1863095676 hasConceptScore W1863095676C141071460 @default.
• W1863095676 hasConceptScore W1863095676C143998085 @default.
• W1863095676 hasConceptScore W1863095676C146357865 @default.
• W1863095676 hasConceptScore W1863095676C151730666 @default.
• W1863095676 hasConceptScore W1863095676C191897082 @default.
• W1863095676 hasConceptScore W1863095676C192562407 @default.
• W1863095676 hasConceptScore W1863095676C197934379 @default.
• W1863095676 hasConceptScore W1863095676C2776694085 @default.
• W1863095676 hasConceptScore W1863095676C2777154038 @default.
• W1863095676 hasConceptScore W1863095676C2778456384 @default.
• W1863095676 hasConceptScore W1863095676C2778527123 @default.
• W1863095676 hasConceptScore W1863095676C2778740770 @default.
• W1863095676 hasConceptScore W1863095676C2779013556 @default.
• W1863095676 hasConceptScore W1863095676C526805850 @default.
• W1863095676 hasConceptScore W1863095676C71924100 @default.
• W1863095676 hasConceptScore W1863095676C86803240 @default.
• W1863095676 hasConceptScore W1863095676C90924648 @default.
• W1863095676 hasIssue "11" @default.
• W1863095676 hasLocation W18630956761 @default.
• W1863095676 hasLocation W18630956762 @default.
• W1863095676 hasOpenAccess W1863095676 @default.
• W1863095676 hasPrimaryLocation W18630956761 @default.
• W1863095676 hasRelatedWork W167319750 @default.
• W1863095676 hasRelatedWork W2040004723 @default.
• W1863095676 hasRelatedWork W2376769477 @default.
• W1863095676 hasRelatedWork W2465617904 @default.
• W1863095676 hasRelatedWork W2887323301 @default.

• next